Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey

New Microbiologica

Volumn 31, Issue 3, 2008, Pages 401-408

  Kuzucu, Cigdem ^a   Durmaz, Riza ^a   Otlu, Baris ^a   Aktas, Elif ^b   Gulcan, Hande ^c   Cizmeci, Zeynep ^d  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

^d Microbiology Laboratory   (Turkey)

Author keywords

Antifungal susceptibility testing; Arbitrarily primed polymerase chain reaction; Bloodstream infections; Candida spp.; Electrophoretic karyotyping; Neonatal intensive care unit

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ARTICLE; CANDIDA; CANDIDIASIS; CHILD; DRUG EFFECT; FEMALE; GENETICS; HUMAN; INFANT; INTENSIVE CARE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MORTALITY; NEWBORN; NEWBORN INTENSIVE CARE; PRESCHOOL CHILD; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUCONAZOLE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE UNITS, PEDIATRIC; ITRACONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; TURKEY;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 52749091267     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. AVILA-AGUERO M.L., CANAS-COTO A., ULLOA-GUTIERREZ R., CARO M.A., ALFARO B., PARIS M.M. (2005). Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica. International Journal of Infectious Diseases. 9, 90-95.
2. AYAN M., DURMAZ R., AKTAS E., DURMAZ B. (2003a). Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital. Journal of Hospital Infection. 54, 39-45.
3. AYAN M., KUZUCU C., DURMAZ R., AKTAS E., CIZMECI Z. (2003b). Analysis of three outbreaks due to Klebsiella species in a neonatal intensive care unit. Infection Control and Hospital Epidemiology. 24, 495-500.
4. BARCHIESI F., CAGGIANO G., FALCONI D.E, MONTAGNA M.T., BARBUTI S., SCALISE G. (2004). Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit. Diagnostic Microbiology and Infectious Disease. 49, 269-271.
5. BENDEL C.M. (2003). Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis. Seminars in Perinatology. 27, 357-364.
6. BOCCIA S., POSTERARO B., LA SORDA M., VENTO G., MATASSA PG., TEMPERA A., PETRUCCI S., FADDA G. (2002). Genotypic analysis by 27A DNA finger-printing of Candida albicans strains isolated during an outbreak in a neonatal intensive care unit. Infection Control and Hospital Epidemiology. 23, 281-284.
7. CLINICAL AND LABORATORY STANDARDS INSTITUTE. (2002). Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard-second edition. CLSI publication no. M27-A2 Wayne, PA:CLSI 2002.
8. DURMAZ R., DURMAZ B., BAYRAKTAR M., OZEROL I.H., KALCIOGLU M.T., AKTAS E., CIZMECI Z. (2003). Prevalence of group A streptococcal carriers in asymptomatic children and clonal relatedness among isolates in Malatya, Turkey. Journal of Clinical Microbiology. 41, 5285-5287.
9. FEJA K.N., WU F., ROBERTS K., LOUGHREY M., NESIN M., LARSON E., DELLA-LATTA P., HAAS J., CIMIOTTI J., SAIMAN L. (2005). Risk factors for candidemia in critically ill infants: a matched case-control study. Journal of Pediatrics. 147, 156-161.
10. GAGNEUR A., SIZUN J., VERNOTTE E., DE PARSCAU L., QUINIO D., LE FLOHIC A.M., BARON R. (2001). Low rate of Candida parapsilosis-related colonization and infection in hospitalized preterm infants: a one-year prospective study. Journal of Hospital Infection. 48, 193-197.
11. GULCAN H., KUZUCU C., DURMAZ R. (2004). Nosocomial Stenotrophomonas maltophilia cross-infection: three cases in newborns. American Journal of Infection Control. 32, 365-368.
12. GUNGOR S., OZEN M., AKINCI A., DURMAZ R. (2003). A Chryseobacterium meningosepticum outbreak in a neonatal ward. Infection Control and Hospital Epidemiology. 24, 613-617.
13. HEDDERWICK S.A., LYONS M.J., LIU M., VAZQUEZ J.A., KAUFFMAN C.A. (2000). Epidemiology of yeast colonization in the intensive care unit. European Journal of Clinical Microbiology & Infections Diseases. 19, 663-670.
14. HUANG, Y.C., SU L.H., WU T.L., LIN T.Y. (2004). Gcnotyping analysis of colonizing candidat isolates from very-low-birthweight infants in a neonatal intensive care unit. Journal of Hospital Infection. 58, 200-203.
15. LEIBOVITZ E. (2002). Neonatal candidosis: clinical picture, management controversies and consensus, and new therapeutic options. Journal of Antimicrobial Chemotherapy. 49 (Suppl 1): 69-73.
16. LINDER N., KLINGER G., SHALIT I., LEVY I., ASHKENAZI S., HASKI G., LEVIT O., SIROTA L. (2003). Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations. Journal of Antimicrobial Chemotherapy. 52, 663-667.
17. LOPEZ-RIBOT J.L., MCATEE R.K., KIRKPATRICK W.R., PEREA S., PATTERSON T.F. (2000). Comparison of DNA-based typing methods to assess genetic diversity and relatedness among Candida albicans clinical isolates. Revista Iberoamericana De Micología. 17, 49-54.
18. MORGAN J., MELTZER M.I., PLIKAYTIS B.D., SOFAIR A.N., HUIE-WHITE S., WILCOX S., HARRISON L.H., SEABERG; E.G., HAJJEH R.A..TEUTSCH S.M. (2005). Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infection Control and Hospital Epidemiology. 26, 540-547.
19. PFALLER M.A., DIEKEMA D.J. (2004). Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clinical Microbiology and Infection. 10 (Suppl 1), 11-23.
20. PFALLER M.A., DIEKEMA D.J., JONES R.N., MESSER S.A., HOLLIS R.J. (2002). Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. Journal of Clinical Microbiology. 40, 852-856.
21. PFALLER M.A., DIEKEMA D.J., MESSER S.A., BOYKEN L., HOLLIS R.J., JONES R.N. (2004). In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagnostic Microbiology and Infectious Disease, 48, 101-105.
22. REEF S.E., LASKER B.A., BUTCHER D.S., MCNEIL M.M., PRUITT R., KEYSERLING H., JARVIS W.R. (1998).
23. Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. Journal of Clinical Microbiology. 36, 1255-1259.
24. ROILIDES E., FARMAKI E., EVDORIDOU J., DOTIS J., HATZIIOANNIDIS E., TSIVITANIDOU M., BIBASHI E., FILIOTI I., SOFIANOU D., GIL-LAMAIGNERE C., MUELLER F.M., K REMENOPOULOS G. (2004). Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. European Journal of Clinical Microbiology & Infections Diseases. 23, 745-750.
25. ROILIDES E., FARMAKI E., EVDORIDOU J., FRANCESCONI A., KASAI M., FILIOTI J., TSIVITANIDOU M., SOFIANOU D., KREMENOPOULOS G., WALSH T.J. (2003). Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. Journal of Clinical Microbiology. 41, 735-741.
26. SAIMAN L. (1998). Neonatal candidiasis. Diagnostic Microbiology and Infectious Disease. 20, 149-152.
27. SAN MIGUEL L.G., COBO J., OTHEO E., SANCHEZ-SOUSA A., ABRAIRA V., MORENO S. (2005). Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis. Infection Control and Hospital Epidemiology. 26, 548-552.
28. SHIN J.H., SHIN D.H., SONG J.W., KEE S.J., SUH S.P., RYANG D.W. (2001). Elcctrophoretic karyotype analysis of sequential Candida parapsilosis isolates from patients with persistent or pecurrent fungemia. Journal of Clinical Microbiology. 39, 1258-1263.
29. SINGHI S.C., REDDY T.C., CHAKRABARTI A. (2004). Candidemia in a pediatriC intensive care unit. Pediatric Critical Care Medicine. 5, 369-374.
30. VERDUYN LUNEL P.M., MEIS J.E, Voss A. (1999). Nosocomial fungal infections: candidemia. Diagnostic Microbiology and Injections Disease. 34, 213-220.
31. VRIONI G, MATSIOTA-BERNARD P. (2001). Molecular typing of Candida isolates from patients hospitalized in an intensive care unit. Journal of Infection. 42, 50-56.
32. ZAOUTIS T.E., FORAKER E., MCGOWAN K.L., MORTENSEN J., CAMPOS J., WALSH T.J., KLEIN J.D. (2005). Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Diagnostic Microbiology and Infectious Disease. 52, 295-298.